SHARJAH / WAM The Sharjah Chamber of Commerce and Industry (SCCI) has discussed with the ...
Read More »Pfizer’s GBT deal to aid more sickle-cell patients
Pfizer continues to spend its Covid windfall wisely. The pharma company said it would spend $5.4 billion to buy Global Blood Therapeutics (GBT), which has one approved drug to treat sickle-cell disease and two more in development. It’s a smart deal for both companies. Pfizer can put needed marketing muscle behind GBT’s products. In return, Pfizer will be able ...
Read More »